SomatoPulse (Tesa 10mg/Ipamorelin 3mg) For Sale

SomatoPulse combines 10mg Tesamorelin with 3mg Ipamorelin in a single lyophilized vial to allow investigation of complementary growth hormone signaling pathways.

By pairing Tesamorelin, Growth Hormone–Releasing Hormone (GHRH) analog, with Ipamorelin, a selective ghrelin receptor agonist, SomatoPulse is designed to support dual-receptor stimulation of endogenous growth hormone release within controlled laboratory models.

Tesamorelin (10mg)  – a synthetic analog of Growth Hormone–Releasing Hormone (GHRH). It is designed to stimulate the anterior pituitary gland to produce and release endogenous growth hormone (GH) in a physiologic, pulsatile manner.

Ipamorelin (3mg) – a selective growth hormone secretagogue (GHS) studied for its ability to stimulate endogenous growth hormone (GH) release by activating the ghrelin (GHSR-1a) receptor in the pituitary.

At Orbitrex Peptides, we understand the importance of precision, consistency, and innovation in peptide-based research. Our SomatoPulse Blend formulation is designed to provide researchers with a cutting-edge solution that aligns with the highest scientific standards.

SomatoPulse Blend undergoes rigorous quality control procedures and independent 3rd-party verification, guaranteeing 99%+ purity for every vial. This commitment to transparency ensures that researchers can move forward with confidence, knowing they are working with a peptide blend that has been tested, validated, and proven to meet stringent specifications.

Packaged in secure, sterile vials, Wolverine Blend is supplied in lyophilized powder form, which provides ease of handling, long-term stability, and reliable performance across various controlled applications. Whether you’re part of a laboratory team or an independent researcher, SomatoPulse offers the balance of reliability, consistency, and value.

Technical Specifications